FB VISION is a new ophthalmic company, part of "FB" international scientific research Group. FB VISION was founded in 2015 with the mission of researching, developing and manufacturing high quality products for the prevention and treatment of pathologies affecting the eyes. The main therapeutic areas are: GLAUCOMA, OCULAR SURFACE, NEUROPROTECTION and OCULAR SURGERY. FB are initials of Francesco Bellini, Chairman and Founder of the Group. Dr. Bellini is an Italian naturalized Canadian pioneer scientist-entrepreneur in the Canadian bio-pharmaceutical industry. FB VISION is made up of a team of professionals with a strong experience in the ophthalmic industry and it aims at becoming a landmark for ophthalmologists and patients.